VCYT
Veracyte Inc
NASDAQ: VCYT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$32.92
+3.59% today
Updated 2026-04-30
Market cap
$2.67B
P/E ratio
40.77
P/S ratio
5.16x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$23 – $51
Volume
0.9M
Veracyte Inc (VCYT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
12.80%
Operating margin
17.50%
ROE
5.34%
ROA
2.91%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $2.65M | $-14.45M | -10.59% | -577.16% | -546.12% |
| 2012 | $11.63M | $-18.65M | 34.78% | -162.79% | -160.38% |
| 2013 | $21.88M | $-25.58M | 42.39% | -105.89% | -116.89% |
| 2014 | $38.19M | $-29.37M | 56.52% | -75.95% | -76.91% |
| 2015 | $49.50M | $-33.70M | 56.57% | -67.60% | -68.08% |
| 2016 | $65.08M | $-31.36M | 60.88% | -44.25% | -48.18% |
| 2017 | $71.95M | $-31.00M | 60.81% | -36.88% | -43.09% |
| 2018 | $92.01M | $-23.00M | 64.05% | -24.16% | -25.00% |
| 2019 | $120.37M | $-12.60M | 69.66% | -12.57% | -10.47% |
| 2020 | $117.48M | $-34.91M | 64.71% | -30.12% | -29.71% |
| 2021 | $219.51M | $-75.56M | 66.11% | -37.31% | -34.42% |
| 2022 | $296.54M | $-36.56M | 65.74% | -13.85% | -12.33% |
| 2023 | $361.05M | $-74.40M | 68.73% | -23.76% | -20.61% |
| 2024 | $445.76M | $24.14M | 66.88% | 3.62% | 5.41% |
| 2025 | $517.14M | $66.35M | 69.62% | 14.34% | 12.83% |